HLA-partially matched cellular therapy (stem-cell microtransplantation) for acute myeloid leukaemia: Description of four cases

British Journal of Haematology

Volumn 165, Issue 4, 2014, Pages 580-581

  Forés, Rafael ^a   Dorado, Nieves ^a   Vilches, Carlos ^a   Regidor, Carmen ^a   García Marco, José A ^a   De Pablo, Rosario ^a   De Laiglesia, Almudena ^a   Lario, Ana ^a   Piris, Miguel ^a   Cabrera, J Rafael ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Acute myeloid leukaemia; Cellular therapies; Immunotherapy; Stem cell transplantation

Indexed keywords

AZACITIDINE; CYTARABINE; HLA A ANTIGEN; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; APHERESIS; ARTICLE; CASE REPORT; CATHETER INFECTION; CYTOGENETICS; DONOR LYMPHOCYTE INFUSION; FEVER; HUMAN; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RASH; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; STEM CELL TRANSPLANTATION; THROMBOCYTHEMIA; TREATMENT DURATION;

ACUTE MYELOID LEUKAEMIA; CELLULAR THERAPIES; IMMUNOTHERAPY; STEM CELL TRANSPLANTATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZACITIDINE; CYTARABINE; GRAFT SURVIVAL; GRAFT VS LEUKEMIA EFFECT; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IDARUBICIN; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE TRANSFUSION; MALE; MIDDLE AGED; REMISSION INDUCTION; TISSUE DONORS;

EID: 84899492239     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12771     Document Type: Article

References (5)

1. Ai, H., Hu, K, Sun, Q., Li, X., Guo, M., Yu, C., Qiao, J., Qiao, J., Liu, G., Dong, Z. & Qiao, Z. (2012) Microtransplantation with decitabine and cytarabine improves patient outcomes in myelodysplastic syndromes. Blood (ASH Annual Meeting Abstracts), 120, 1709.
2. Cignetti, A., Ruella, M., Elia, A.R., Tassi, V., Redoglia, V., Gottardi, D. & Tarella, C. (2013) Haploidentical cellular therapy in elderly patients with acute myeloid leukemia: description of his use in high risk patients. American Journal of Hematology, 88, 720-721.
3. Guo, M., Hu, K.X., Yu, C.L., Sun, Q.Y., Qiao, J.H., Wang, D.H., Liu, G.X., Sun, W.J., Wei, L., Sun, X.D., Huang, Y.J., Qiao, J.X., Dong, Z. & Ai, H.S. (2011) Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukaemia in elderly patients. Blood, 117, 936-941.
4. Guo, M., Hu, K.X., Liu, G.X., Yu, C.L., Qiao, J.H., Sun, Q.Y., Qiao, J.X., Dong, Z., Sun, W.J., Sun, X.D., Zuo, H.L., Man, Q.H., Liu, Z.Q., Liu, T.Q., Zhao, H.X., Huang, Y.J., Wei, L., Liu, B., Wang, J., Shen, X.L. & Ai, H.S. (2012) HLA-mismatched stem-cell microtransplantation as posremission therapy for acute myeloid leukemia: long-term follow-up. Journal of Clinical Oncology, 30, 4084-4090.
5. Reagan, J.L., Fast, L.D., Safran, H., Nevola, M., Winer, E.S., Castillo, J.J., Butera, J.N., Quesenberry, M.I., Young, C.T. & Quesenberry, P.J. (2012) Nonengraftment haploidentical cellular therapy for hematologic malignancies. Advances in Hematology, 2012, 1-6.